Novel and future lipid-modulating therapies for the prevention of cardiovascular disease-Reference-Cited by-同舟云学术

Novel and future lipid-modulating therapies for the prevention of cardiovascular disease

Published:2023-04-13 Issue:9 Volume:20 Page:600-616
ISSN:1759-5002
Container-title:Nature Reviews Cardiology
language:en
Short-container-title:Nat Rev Cardiol

Author:

Brandts Julia^ORCID,Ray Kausik K.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

https://www.nature.com/articles/s41569-023-00860-8.pdf

Reference196 articles.

1. World Health Organization. Cardiovascular diseases (CVDs) WHO https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (2021).

2. Ference, B. A. et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur. Heart J. 38, 2459–2472 (2017).

3. Trialists, C. T. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 380, 581–590 (2012).

4. Duran, E. K. & Pradhan, A. D. Triglyceride-rich lipoprotein remnants and cardiovascular disease. Clin. Chem. 67, 183–196 (2021).

5. Ginsberg, H. N. et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies – a consensus statement from the European Atherosclerosis Society. Eur. Heart J. 42, 4791–4806 (2021).

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cathepsin B in cardiovascular disease: Underlying mechanisms and therapeutic strategies;Journal of Cellular and Molecular Medicine;2024-09

2. Effects of dietary glycerol monolaurate on growth and digestive performance, lipid metabolism, immune defense and gut microbiota of shrimp (Penaeus vannamei);Fish & Shellfish Immunology;2024-08

3. Exploring the Perceptions and Behaviours of UK Prescribers Concerning Novel Lipid-Lowering Agent Prescriptions: A Qualitative Study;Pharmacy;2024-07-03

4. Advances in nucleic acid-targeted therapies for cardiovascular disease prevention;Cardiovascular Research;2024-07

5. Micronano Synergetic Three-Dimensional Bioelectronics: A Revolutionary Breakthrough Platform for Cardiac Electrophysiology;ACS Nano;2024-06-05